2-Morpholinopyridine-3-boronic acid
Product Information
Molecular Formula
C9H13BN2O3
Molecular Weight
208.0
Description
2-Morpholinopyridine-3-boronic acid is an important biomedical ingredient. It can inhibit the expansion and replication of malignant tumor cells, thereby promoting drug development against complex malignancies such as breast cancer and lung cancer.
Synonyms
(2-morpholin-4-ylpyridin-3-yl)boronicacid; 2-Morpholinopyridine-3-boronicacid; 1218790-86-3; (2-Morpholinopyridin-3-yl)boronicacid; ACMC-209ain; SCHEMBL15743182
IUPAC Name
(2-morpholin-4-ylpyridin-3-yl)boronic acid
SMILES
B(C1=C(N=CC=C1)N2CCOCC2)(O)O
InChI
InChI=1S/C9H13BN2O3/c13-10(14)8-2-1-3-11-9(8)12-4-6-15-7-5-12/h1-3,13-14H,4-7H2
InChI Key
SWDPLAALYQOCHB-UHFFFAOYSA-N
Melting Point
90-94 °C
Flash Point
Not applicable
Purity
95%
Storage
2-8°C
Safety Information
Hazards
H302
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
208.1019224 g/mol
Monoisotopic Mass
208.1019224 g/mol
Topological Polar Surface Area
65.8Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
200
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-110997671-A | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| EP-3634962-A1 | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| TW-201920165-A | Nitrogen-based compound as a histone methyltransferase inhibitor | 2017-06-09 |
| US-2018354947-A1 | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| WO-2018226998-A1 | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| BR-112019025770-A2 | AZAINDOL COMPOUNDS AS HYSTONE METHYLTRANSPHERASE INHIBITORS | 2017-06-09 |
| JP-2020523315-A | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| US-11111243-B2 | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| US-2021371417-A1 | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| US-2014256704-A1 | Substituted 1H-Pyrrolo [2, 3-b] pyridine and 1H-Pyrazolo [3, 4-b] pyridine Derivatives as Salt Inducible Kinase 2 (SIK2) Inhibitors | 2012-12-14 |
